Unique ID issued by UMIN | UMIN000051430 |
---|---|
Receipt number | R000058667 |
Scientific Title | Observational study to elucidate the pathogenesis of portal hypertension in diffuse liver disease using perfusion CT |
Date of disclosure of the study information | 2023/06/23 |
Last modified on | 2023/06/23 15:49:23 |
Observational study to elucidate the pathogenesis of portal hypertension in diffuse liver disease using perfusion CT
Observational study to elucidate the pathogenesis of portal hypertension in diffuse liver disease using perfusion CT
Observational study to elucidate the pathogenesis of portal hypertension in diffuse liver disease using perfusion CT
Observational study to elucidate the pathogenesis of portal hypertension in diffuse liver disease using perfusion CT
Japan |
diffuse liver disease
Hepato-biliary-pancreatic medicine |
Others
NO
Perfusion CT is performed before and after treatment involving alteration of portal blood flow in patients with diffuse liver disease. Evaluate changes in portal vein blood flow and arterial blood flow before and after treatment, and seek to elucidate the pathology. In addition, we will elucidate the characteristics of blood flow distribution in non-cirrhotic liver diseases such as idiopathic portal hypertension (IPH), Budd-Chiari syndrome, and extrahepatic portal vein occlusion (EHO).
Efficacy
Evaluation of changes in portal vein perfusion and arterial perfusion by perfusion CT
Observational
20 | years-old | <= |
Not applicable |
Male and Female
1) Patients with diffuse liver disease
2) Patients with pathological conditions associated with portal hypertension and scheduled perfusion CT examination in routine practice for evaluation of treatment involving alteration of portal blood flow
3) Patients aged 20 years or older at the time of informed consent
4) Patients who have given written informed consent of their own free will after receiving sufficient explanation about participating in this study.
1) Patients who are examined in routine clinical practice and who are judged by the principal investigator or sub-investigator to be inappropriate for conducting this study safely
100
1st name | Naoya |
Middle name | |
Last name | Kato |
Chiba University Hospital
Gastroenterology
2608677
1-8-1 Chuo Ward, Chiba City, Chiba Prefecture
043222717
kato.naoya@chiba-u.jp
1st name | Takayuki |
Middle name | |
Last name | Kondo |
Chiba University Hospital
Gastroenterology
2608677
1-8-1 Chuo Ward, Chiba City, Chiba Prefecture
0432227171
takakon@chiba-u.jp
Chiba University
Chiba University
Self funding
Chiba University Hospital
1-8-1 Chuo Ward, Chiba City, Chiba Prefecture
0432227171
fujimoto.kentarou@chiba-u.jp
NO
2023 | Year | 06 | Month | 23 | Day |
Unpublished
Open public recruiting
2023 | Year | 04 | Month | 27 | Day |
2023 | Year | 04 | Month | 27 | Day |
2023 | Year | 04 | Month | 27 | Day |
2025 | Year | 12 | Month | 31 | Day |
Perfusion CT is performed before and after treatment involving alteration of portal blood flow in patients with diffuse liver disease. Evaluate changes in portal vein blood flow and arterial blood flow before and after treatment, and seek to elucidate the pathology. In addition, we will elucidate the characteristics of blood flow distribution in non-cirrhotic liver diseases such as idiopathic portal hypertension (IPH), Budd-Chiari syndrome, and extrahepatic portal vein occlusion (EHO).
2023 | Year | 06 | Month | 23 | Day |
2023 | Year | 06 | Month | 23 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000058667